ClinConnect ClinConnect Logo
Search / Trial NCT05699525

Personalized Mobile Cognitive Behavioral Therapy Application

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jan 17, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new mobile app called Maya, designed to help improve symptoms of anxiety, depression, and bipolar disorder through cognitive behavioral therapy (CBT). The trial will compare a standard version of the app with a personalized version that introduces new skills over a shorter time frame. Participants, aged 18 to 25, who have been diagnosed with one of these conditions, will use the app for at least 20 minutes, two days a week for six weeks. They'll also have weekly check-ins with a research team member and may choose to undergo brain scans at the beginning and end of the study.

To participate, individuals must have a primary diagnosis of anxiety, depression, or bipolar disorder and own an Apple iPhone. However, those with certain conditions, such as a history of serious neurological issues or currently experiencing a manic episode, cannot join. The goal of this trial is to see if the personalized app is just as effective as the standard version while being easier to use. This could lead to better treatment options for young people dealing with these mental health challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 and 25 years.
  • Primary diagnosis of an anxiety, depressive, or bipolar disorder as determined by a score of 4 or greater on the Clinical Severity Rating of the Anxiety Disorders Interview Schedule (ADIS).
  • If an individual is diagnosed with bipolar disorder, they must be currently euthymic or experiencing a depressive episode.
  • Access to an Apple iPhone
  • Exclusion Criteria:
  • History of neurologic disorder that may affect the neural systems of interest or participant's ability to participate
  • Lifetime diagnosis of a psychotic disorder.
  • Current hypomanic or manic episode.
  • Currently in cognitive behavior therapy.
  • Change in dose of a psychiatric medication in the past 12 weeks.
  • Initiation of psychotherapy in the past 12 weeks.
  • Intent or plan to attempt suicide.

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

New York, New York, United States

Patients applied

HV

1 patients applied

Trial Officials

Jennifer Bress, Ph.D.

Principal Investigator

Weill Medical College of Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials